GlassScriptPhysician profile
Luis A Gonzalez
NPI 1679660260
$7,582.77
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,359 · 2021: $1,140 · 2022: $83.89.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,297.01 | 2019 | |
| Applied Medical Resources Corporation | $973.52 | 2021 | |
| Gilead Sciences, INC. | $65.16 | 2021 | |
| Novo Nordisk INC | $50.17 | 2021-2022 | |
| Olympus America INC. | $35.81 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $25.61 | 2021-2022 | |
| Abbvie INC. | $21.37 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $20.37 | 2022 | |
| Janssen Pharmaceuticals, INC | $16.90 | 2021 | |
| Amag Pharmaceuticals, INC. | $13.27 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.14 | 2019 | |
| Organon LLC | $12.93 | 2022 | |
| Merck Sharp & Dohme LLC | $12.93 | 2021 | |
| Abbott Laboratories | $12.52 | 2021 | |
| Amarin Pharma, INC. | $12.06 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.